Change regional settings
for the treatment of angiopathy, glaucoma, cataracts
The isolated peptides prevent the development of retinal degeneration, normalize metabolism and prevent the development of retinal degeneration and optic nerve atrophy.
*In case of wet macular degeneration, edema, hemorrhages in the retina, only Visoluten and Retisil can be used. In retinal sclerosis (fibrosis), the use of retinal peptides is contraindicated.
Revilab ML 03 | Prevent optic nerve atrophy |
Pinalex | Prevent retinal degeneration |
Visoluten №60 | Prevent the development of the retinal degeneration |
Церлутен №60 | Prevent the development of the retinal degeneration |
Ventfort №60 | Normalizes the condition of the vascular wall |
Visoluten №60 | Prevent the development of the retinal degeneration |
Церлутен №60 | Prevent the development of the retinal degeneration |
Ventfort №60 | Normalizes the condition of the vascular wall |
Retisil | Promotes a noticeable improvement in blood circulation and metabolism in the retina |
Peptide Complex №17 | Nourishes eye tissues and improves their metabolism |
Visoluten №60 | Prevent the development of the retinal degeneration |
Церлутен №60 | Prevent the development of the retinal degeneration |
Ventfort №60 | Normalizes the condition of the vascular wall |
Retisil | Promotes a noticeable improvement in blood circulation and metabolism in the retina |
Peptide Complex №17 | Nourishes eye tissues and improves their metabolism |
Revilab ML 03 | Prevent optic nerve atrophy |
Pinalex | Prevent retinal degeneration |
Visoluten №60 | Prevent the development of the retinal degeneration |
Церлутен №60 | Prevent the development of the retinal degeneration |
Ventfort №60 | Normalizes the condition of the vascular wall |
Title | Quantity | Directions for use | Mechanism of action | ||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||
|